RxDoctor Payments Data

Yvonne Rodriguez, MD

Family Medicine · Long Beach, CANPI 1720389919

Payments from drug & device makers

$5,552in general payments, 2019–2025

Across 289 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$702
  • Johnson & Johnson$663
  • GSK$459
  • Regeneron Healthcare Solutions, Inc.$369
  • Novo Nordisk$343
  • Lilly USA, LLC$324
  • plus $3K from 37 others

What the payments were for

  • Food & beverage$5,532100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,552 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$27,674
Medicare patients
93
Services billed
481

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin22$31,863
TrulicityDulaglutide15$14,802
JanuviaSitagliptin Phosphate13$11,678
Atorvastatin Calcium165$1,580
Fluoxetine Hcl39$1,441
Olmesartan Medoxomil53$1,403
SynthroidLevothyroxine Sodium12$1,377
Metoprolol Succinate66$1,215
Levothyroxine Sodium84$1,068
ValacyclovirValacyclovir Hcl11$1,013
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide12$882
Rosuvastatin Calcium62$830
Losartan Potassium65$635
Ezetimibe16$564
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$560

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$702$31,86322 claims
Lilly USA, LLCTrulicity$324$14,80215 claims
MerckJanuvia$182$11,67813 claims
AbbVieSynthroid$276$1,37712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.

Other family medicine in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →